Suppr超能文献

细胞因子诱导人B淋巴细胞通过其CD40抗原触发增殖和免疫球蛋白产生。

Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.

作者信息

Rousset F, Garcia E, Banchereau J

机构信息

Laboratory for Immunological Research, Schering-Plough, Dardily, France.

出版信息

J Exp Med. 1991 Mar 1;173(3):705-10. doi: 10.1084/jem.173.3.705.

Abstract

Human resting B lymphocytes enter a state of sustained proliferation when incubated with both mouse fibroblastic L cells stably expressing Fc gamma RII/CDw32 and anti-CD40 antibodies. We have explored the effects of 11 recombinant human cytokines (CKs) on induced cell proliferation and immunoglobulin (Ig) production. Interleukin 4 (IL-4) was the only CK able to enhance anti-CD40-induced B cell multiplication as measured by enumeration of viable cells, and interferon gamma (IFN-gamma) further stimulated this induced proliferation. IL-4 enhanced the production of IgM and IgG by B cells and induced them to produce IgE. Combinations of IL-4 and IL-2 resulted in the production of large amounts of IgM and IgA. Interestingly, IFN-gamma did not inhibit the production of IgE by cells stimulated with anti-CD40 and IL-4. None of the tested CK combinations resulted in the production of large quantities of IgG. Therefore, this new culture system represents a unique model to study isotype regulation in highly purified human B lymphocytes, in addition to allowing the generation of long-term factor-dependent human B cell lines.

摘要

当与稳定表达FcγRII/CDw32的小鼠成纤维细胞L细胞和抗CD40抗体一起孵育时,人静息B淋巴细胞会进入持续增殖状态。我们研究了11种重组人细胞因子(CKs)对诱导的细胞增殖和免疫球蛋白(Ig)产生的影响。白细胞介素4(IL-4)是唯一能够通过活细胞计数来增强抗CD40诱导的B细胞增殖的CK,而干扰素γ(IFN-γ)进一步刺激这种诱导的增殖。IL-4增强了B细胞产生IgM和IgG的能力,并诱导它们产生IgE。IL-4和IL-2的组合导致产生大量的IgM和IgA。有趣的是,IFN-γ并不抑制由抗CD40和IL-4刺激的细胞产生IgE。所测试的CK组合均未导致产生大量的IgG。因此,这种新的培养系统除了能够产生长期依赖因子的人B细胞系外,还代表了一种研究高度纯化的人B淋巴细胞中同种型调节的独特模型。

相似文献

引用本文的文献

1
Reduction of TRAF3 by heterozygosity or aging impacts B cell function.杂合性或衰老导致的TRAF3减少会影响B细胞功能。
Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2507217122. doi: 10.1073/pnas.2507217122. Epub 2025 Aug 7.
3
Engineering cytokine therapeutics.工程化细胞因子疗法
Nat Rev Bioeng. 2023;1(4):286-303. doi: 10.1038/s44222-023-00030-y. Epub 2023 Feb 16.
5
COVID-19 in the tonsillectomised population.扁桃体切除术后人群中的 COVID-19。
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):197-205. doi: 10.14639/0392-100X-N1436. Epub 2021 May 6.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验